{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:17:04Z","timestamp":1773735424909,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1925,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbmt.2009.10.034","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T07:42:19Z","timestamp":1257406939000},"page":"S48-S56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"S","title":["Hematopoietic Cell Transplantation for Autoimmune Disease: Updates from Europe and the United States"],"prefix":"10.1016","volume":"16","author":[{"given":"Keith M.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.10.034_bib1","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1073\/pnas.82.8.2483","article-title":"Rationale for bone marrow transplantation in the treatment of autoimmune diseases","volume":"82","author":"Ikehara","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2009.10.034_bib2","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1073\/pnas.86.24.10090","article-title":"Regression of adjuvant-induced arthritis in rats following bone marrow transplantation","volume":"86","author":"van Bekkum","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 48","key":"10.1016\/j.bbmt.2009.10.034_bib3","first-page":"23","article-title":"Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation","volume":"24","author":"Nelson","year":"1997","journal-title":"J Rheum"},{"issue":"Suppl 48","key":"10.1016\/j.bbmt.2009.10.034_bib4","first-page":"100","article-title":"Pros and cons of stem cell transplantation for autoimmune disease","volume":"24","author":"Thomas","year":"1997","journal-title":"J Rheum"},{"key":"10.1016\/j.bbmt.2009.10.034_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1023\/A:1006682225181","article-title":"Stem cell transplantation in experimental models of autoimmune disease","volume":"20","author":"van Bekkum","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.148.6.1693","article-title":"Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation","volume":"148","author":"Karussis","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/nen.0b013e318093f3ef","article-title":"Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response","volume":"66","author":"Cassiani-Ingoni","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2009.10.034_bib10","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2009.10.034_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.034_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","article-title":"Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines","volume":"27","author":"Brinkman","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M","article-title":"Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro","volume":"31","author":"Stephens","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2004-01-0328","article-title":"Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease","volume":"104","author":"Anderson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.034_bib17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2004-12-4607","article-title":"Tolerance induction by bone marrow transplantation in a multiple sclerosis model","volume":"106","author":"Herrmann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.034_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/rheumatology\/36.3.390","article-title":"Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"36","author":"Tyndall","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"Suppl 48","key":"10.1016\/j.bbmt.2009.10.034_bib19","first-page":"1","article-title":"The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases","volume":"24","author":"Sullivan","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/ard.55.10.779","article-title":"Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease","volume":"55","author":"Tamm","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2009.10.034_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"35","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.034_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2009.10.034_bib23","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbmt.2009.10.034_bib24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(08)70138-8","article-title":"Autologous haematopoietic stem-cell transplantation in multiple sclerosis","volume":"7","author":"Mancardi","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib25","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-tern follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.034_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erhthematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2009.10.034_bib27","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","article-title":"High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis","volume":"102","author":"Nash","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.034_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","article-title":"Autologous nonmyeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study","volume":"8","author":"Burt","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbmt.2005.07.009","volume":"11","author":"Griffith","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.034_bib30","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-07-5060","article-title":"Development of clinical trials in a cooperative group setting: the Eastern Cooperative Oncology Group","volume":"14","author":"Dilts","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2009.10.034_bib31","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.bmt.1703943","article-title":"Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"32","author":"Burt","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.034_bib32","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1200\/JCO.2005.02.6245","article-title":"Evaluation of factors affecting awareness and willingness to participate in cancer clinical trials","volume":"23","author":"Lara","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib33","doi-asserted-by":"crossref","first-page":"w533","DOI":"10.1377\/hlthaff.28.4.w533","article-title":"What does it cost physician practices to interact with health insurance plans?","volume":"28","author":"Casalino","year":"2009","journal-title":"Health Affairs"},{"key":"10.1016\/j.bbmt.2009.10.034_bib34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.2003.02.105","article-title":"Public attitudes toward participation in cancer clinical trials","volume":"21","author":"Comis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.10.034_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199402173300707","article-title":"Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer","volume":"330","author":"Peters","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.10.034_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199402173300711","article-title":"Life, death and the insurance companies","volume":"330","author":"Light","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.10.034_bib37","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.10.034_bib38","series-title":"Horizon Scan: To What Extent Do Changes in Third Party Payment Affect Clinical Trials and the Evidence Base?","year":"2009"},{"key":"10.1016\/j.bbmt.2009.10.034_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1744-313X.2006.00592.x","article-title":"Biobanks and registries for HSCT research: potential for future individualized medicine","volume":"33","author":"Dickinson","year":"2006","journal-title":"Int J Immunogenet"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109005163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109005163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:12Z","timestamp":1761057312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109005163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1083879109005163"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.10.034","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Cell Transplantation for Autoimmune Disease: Updates from Europe and the United States","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}